Stocks / NASDAQ / RenovoRx Inc.

RenovoRx Inc.

Our Opinion

RenovoRx Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Using the RenovoTAMP technique in explanted (dissectedout of the animal and used separately in a saline water bath) pig aorta and iliac arteries, we were able to validate our hypothesisby demonstrating >99% gemcitabine pressurized diffusion across the arterial wall in the absence of feeder vessels.” (Page 7) Read the full document

Company Description

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing therapies for the local treatment of solid tumors and conducting a Phase III pancreatic cancer clinical trial for its lead product candidate RenovoGem. The Company’s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) utilizes chemotherapeutics.

Company Website: